HIMS
Company Description
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.35B | 1.48B | 872.00M | 526.92M | 271.88M | 148.76M | 82.56M |
| Net Income | 128.37M | 126.04M | (23.55M) | (65.68M) | (107.66M) | (18.11M) | (72.06M) |
| EPS | 0.57 | 0.58 | -0.11 | -0.32 | -0.58 | -0.51 | -2.07 |
| Free Cash Flow | 73.96M | 198.33M | 46.99M | (33.78M) | (39.42M) | (6.71M) | (76.65M) |
| FCF / Share | 0.33 | 0.92 | 0.22 | -0.17 | -0.21 | -0.19 | -2.21 |
| Operating CF | 300.01M | 251.08M | 73.48M | (26.53M) | (34.41M) | (2.48M) | (74.87M) |
| Total Assets | 2.15B | 707.54M | 441.19M | 366.34M | 420.58M | 118.70M | 72.07M |
| Total Debt | 1.12B | 11.35M | 9.95M | 5.31M | 5.48M | 0 | 1.51M |
| Cash & Equiv | 228.62M | 220.58M | 96.66M | 46.77M | 71.78M | 27.34M | 22.65M |
| Book Value | 540.93M | 476.72M | 344.03M | 311.74M | 334.62M | (146.87M) | (135.29M) |
| Return on Equity | 0.24 | 0.26 | -0.07 | -0.21 | -0.32 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 608.10M | 617.82M | 598.98M | 544.83M | 586.01M | 481.14M | 401.56M | 315.65M | 278.17M | 246.62M | 226.70M | 207.91M |
| Net Income | (92.11M) | 20.60M | 15.77M | 42.51M | 49.48M | 26.02M | 75.59M | 13.30M | 11.13M | 1.25M | (7.57M) | (7.16M) |
| EPS | -0.40 | 0.09 | 0.07 | 0.19 | 0.22 | 0.12 | 0.35 | 0.06 | 0.05 | 0.01 | -0.04 | -0.03 |
| Free Cash Flow | 53.03M | 821,000 | 91.42M | (69.43M) | 50.05M | 59.50M | 79.39M | 47.57M | 11.88M | 10.79M | 19.27M | 9.96M |
| FCF / Share | 0.23 | 0.00 | 0.40 | -0.31 | 0.23 | 0.27 | 0.37 | 0.22 | 0.06 | 0.05 | 0.09 | 0.05 |
| Operating CF | 89.36M | 64.70M | 148.72M | (19.12M) | 109.09M | 86.39M | 85.27M | 53.59M | 25.84M | 21.98M | 25.19M | 16.83M |
| Total Assets | 2.27B | 2.15B | 2.23B | 1.88B | 891.71M | 707.54M | 602.26M | 480.50M | 448.11M | 441.19M | 413.87M | 389.88M |
| Total Debt | 1.13B | 1.12B | 1.12B | 1.04B | 63.38M | 11.35M | 11.36M | 11.47M | 11.82M | 9.95M | 4.68M | 5.09M |
| Cash & Equiv | 222.27M | 228.62M | 345.78M | 1.12B | 273.74M | 220.58M | 165.52M | 129.29M | 105.24M | 96.66M | 58.00M | 65.42M |
| Book Value | 446.17M | 540.93M | 580.98M | 562.70M | 549.26M | 476.72M | 440.05M | 361.97M | 344.48M | 344.03M | 328.56M | 320.07M |
| Return on Equity | -0.21 | 0.04 | 0.03 | 0.08 | 0.09 | 0.05 | 0.17 | 0.04 | 0.03 | 0.00 | -0.02 | -0.02 |